Center on Health Equity and Access

Clinical

Health Care Cost

Health Care Delivery

Insurance

Policy

Technology

Value-Based Care

News

All News

Partners

Press Releases

Product Approvals and Launches

Media

Clinical Spotlight

Enduring Webinars

Guidelines

Insights

Interviews

Medical World News

Microsites

News Network

OnLocation

Payer Perspectives

Peer Exchange

Podcasts

Post Conference Perspectives

Stakeholder Summit

Week in Review

Conferences

Conference Coverage

Conference Listing

Journals

All Journals

The American Journal of Managed Care

The American Journal of Accountable Care

Evidence-Based Oncology

Supplements and Featured Publications

Compendia

Asthma

Atopic Dermatitis

Biosimilars

Breast Cancer

COPD

COVID-19

Cholangiocarcinoma

Chronic Kidney Disease

Colorectal Cancer

Dermatology

Diabetes

Digital Health

Employers

Epilepsy

Heart Failure

Hematology

Hemophilia

Immuno-Oncology

Infectious Disease

Inflammation

Leukemia and Lymphoma

Liver

Lung Cancer

Lupus

Major Depressive Disorder

Medicare

Multiple Myeloma

Myasthenia Gravis

Myelodysplastic Syndromes

Oncology

Ophthalmology

Parkinson Disease

Prostate Cancer

Psoriasis

Pulmonary Arterial Hypertension

Rare Blood

Rare Disease

Reimbursement

Respiratory

Rheumatology

Skin Cancer

Sleep

Spinal Muscular Atrophy

Type 1 Diabetes

Vaccines

Women's Health

Events

Upcoming Webinars

CME/CE

Resources

Exclusive Content

Formulary Central

Interactive Tools

Subscribe

eNewsletter

Mary is the associate editorial director for The American Journal of Managed Care® (AJMC®), The Center for Biosimilars®, and Evidence-Based Oncology™. She joined AJMC® in 2013 and oversees speaker recruitment and panel preparations for AJMC®'s premier annual oncology meeting, Patient-Centered Oncology Care®.

She has a BA in communications and philosophy from Loyola University New Orleans. You can connect with Mary on 

Articles

New data from the POLARIX STUDY show that substituting polatuzumab vedotin for 1 part of a classic first-line chemotherapy combination to manage diffuse large B-cell lymphoma improved progression-free survival without compromising health-related quality-of-life.


Additional Results From POLARIX Study Show Improved PFS With No Reduction in HRQOL

Jared is a freelance writer for The American Journal of Managed Care® (AJMC®), and previously worked as a senior editor for HCPLive® at MJH Life Sciences®.

He has an MA from University of Sioux Falls. You can connect with Jared on 

First steps include assembling equity data and reaching out to veterans’ advocacy groups.

Veterans Health Stakeholders Identify Priorities to Ensure Health Equity in Telehealth 

Rose is a freelance writer for The American Journal of Managed Care® (AJMC®), where she previously worked as an editor.

She has a BA in journalism & media studies and Spanish from Rutgers University. You can connect with Rose on 

A new study estimates that prescription of standard-of-care non–small-cell lung cancer (NSCLC) therapies is lower than expected in Medicaid programs, with significant variation between states. 

Targeted Therapies for NSCLC May Be Underused in Medicaid Programs, Study Suggests

Jaime is a freelance writer for The American Journal of Managed Care® (AJMC®), where she previously worked as an assistant editor.

She has a BA in print journalism from Penn State University. You can connect with Jaime on 

With most previous studies on ocular myasthenia gravis stemming from investigations the neurology field, the present investigators came to their conclusion via neuro-ophthalmic analysis.


Ocular MG Should Be Considered in Patients With Ptosis, Diplopia, Says Study 

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia platforms.

About Us

Contact

Editorial Staff

Editorial Boards

Advertise

Do Not Sell My Information

Terms & Conditions

Privacy Policy

AJMC - Managed Care News, Research, and Expert Insights

Facebook

Twitter

LinkedIn

About AJMC

AJMC Journals

Anniversary

Author Forms

Authors

Nominate a Rising Leader

Institute for Value-Based Medicine

All Coverage

Event Coverage

Stakeholders

Academia

Health System

Payers

Providers

Topics

1rem

Compendium

 Diabetes compendium is a comprehensive resource for clinical news and expert insights for the chronic condition.

According to the CDC, 37.3 million individuals in the United States currently have diabetes, while of these, 8.5 million are 

. In addition, more than 1 in 3 Americans currently have prediabetes—or higher than normal blood sugar levels—but 80% of this population is 

 estimates diagnosed diabetes costs the country $327 billion annually.

Obesity is a key risk factor for type 2 diabetes. Data from 2018 show 

 of the United States population is obese, marking a steep increase from the 30.5% reported in the year 2000.

Type 2 diabetes is preventable, and programs like the 

 (DPP) have been proven to lower disease incidence among those at high risk via dietary changes and other lifestyle interventions.

To learn more about how employers are leveraging the DPP to reduce diabetes rates among their workforce, 

 sat down with Jill Hutt, vice president of member services at the 

Greater Philadelphia Business Coalition on Health

On this episode of Managed Care Cast, Hutt explains the Coalition’s efforts to reduce diabetes rates through the DPP, the impact of COVID-19 on diabetes prevention, and how employers looking to get involved in the initiative can join.

This episode of Managed Care Cast is part of the new 

 Podcast Prevention Series, bringing you the latest news on prevention advancements in disease.

Listen above or through one of these podcast services:

On this episode of Managed Care Cast, Jill Hutt, vice president of member services at the Greater Philadelphia Business Coalition on Health, explains the Coalition’s efforts to reduce diabetes rates through the Diabetes Prevention Program (DPP). 

How Can Employers Leverage the DPP to Improve Diabetes Rates?

In recent years, Congress has taken legislative action to allow veterans to more easily access care in the community that is paid for by the Department of Veterans Affairs, or VA. While this has helped dismantle some barriers to accessing care, it has also raised concerns about care fragmentation, or the extent to which a patient’s health care is spread across multiple providers. An ample body of literature has shown worse care outcomes and higher costs in the presence of care fragmentation, which is thought to arise when the different providers and organizations do not communicate effectively with one another.

On this episode of Managed Care Cast, we’re talking with two coauthors of an Original Research article published in our April 2021 issue. The article, “

Ambulatory Care Fragmentation and Hospitalization Among Veterans With Diabetes

,” examines the association between the system of one’s usual care provider and their level of care fragmentation with their odds of being hospitalized.

The authors joining us today are Lisa M. Kern MD, MPH, associate professor of medicine and of population health sciences at Weill Cornell Medicine, and Drew Helmer, MD, deputy director of the Center for Innovations in Quality, Effectiveness, and Safety at Michael E. DeBakey VA Medical Center in Houston, as well as senior faculty at Baylor College of Medicine.

The authors of a study in the April 2021 issue of The American Journal of Managed Care® discuss the possible reasons behind the link between care fragmentation and hospitalizations in veterans with diabetes, as well as potential opportunities to address disjointed care in the context of the widespread telehealth uptake seen during the COVID-19 pandemic.

Balancing Care Access and Fragmentation for Better Outcomes in Veterans With Diabetes

, 88 million adults have prediabetes, and type 1 and type 2 are both increasing in incidence among younger individuals.

On this episode of Managed Care Cast, we speak with experts from 

, one of the largest health care providers in the mid-Atlantic region, serving patients in Delaware and parts of Maryland, New Jersey, and Pennsylvania.

Hoping to increase the percentage of their patients with diabetes who have a hemoglobin A1C of 9% or lower, in 2019, ChristianaCare implemented a diabetes pilot program at 4 of its primary care sites, partnering each site with an endocrinologist and embedding a behavioral counselor at Primary Care Concord in Chadds Ford, Pennsylvania. With an original goal of growing this patient group by 10% by July of 2019, they instead saw 16% growth.

Marina V. Zeltser, MD, MBA, assistant chief medical information officer for population health and director of population health analytics at ChristianaCare; 

Raymond Carter, MD, clinical leader of primary care at Primary Care Concord; and Edward Feuer, MA, the behavioral health counselor embedded at Dr Carter’s practice sat down with us to discuss the pilot program, the team-based approach with results that exceeded ChristianaCare’s original goals, and how they would like to see the program expand going forward.

Experts Discuss Benefits, Limitations of Pediatric Obesity Interventions

Study Weighs Perceived Benefits, Costs of RDM Adoption for Diabetes Management

Recognizing the Role of Systemic Racism in Diabetes Disparities

On this episode of Managed Care Cast, we speak with experts from ChristianaCare, which implemented a diabetes pilot program at 4 of its primary care sites in 2019 and saw its population of patients with well-controlled disease grow by 16%.

ChristianaCare Innovates Diabetes Care for Patients With Poorly Controlled Disease

 for more severe cases of coronavirus disease 2019 (COVID-19). But recently reported cases of 

 among those with no preexisting risk factors suggest the 2 conditions may have a bidirectional relationship.

Interested in these rare cases, which don’t appear to fit the typical 2 types of 

, Francesco Rubino, MD, a professor of metabolic and bariatric surgery at King’s College London, along with a cohort of clinicians from around the world, devised a global registry of COVID-19-related diabetes to better track and understand this condition.

 Registry was created to establish the extent and characteristics of new-onset, COVID-19-related diabetes, and to investigate its pathogenesis, management and outcomes. On this episode of Managed Care Cast, we speak with Rubino about these new cases, the registry’s progress, and future implications of COVID-19-related diabetes.

Diabetes Risk Factors Dominate Top Causes of Global Mortality, Heighten COVID-19 Risks

Kaiser Study: Severe Obesity Boosts Risk of COVID-19 Death, Especially for the Young

Hyperglycemia Is an Independent Risk Factor of COVID-19 Mortality

Experts Issue Guidance on Concurrent COVID-19, Diabetes Treatment

COVID-19 Risk Demonstrates Importance of Keeping Diabetes Under Control

In this episode of Managed Care Cast, Francesco Rubino, MD, discusses the potential bidirectional relationship between coronavirus disease 2019 (COVID-19) and diabetes.

Database Helps Clinicians Determine Whether COVID-19 Causes Diabetes

The last decade has brought great strides in diabetes care. Better insulins and better technology can allow people with diabetes—both type 1 and type 2&mdash;to keep their blood sugar from rising and falling in ways that cause long-term damage to their eyesight and vascular systems. New classes of drugs for patients with type 2 diabetes have been shown to cut the risk of heart and renal failure, and more widespread use could help some patients avoid dialysis.

But the good news is not felt by everyone. Amid this progress, the rate of amputations rose 50% between 2009 and 2015. African American patients lose limbs at triple the rate of other groups. 

The mission of the Affordable Care Act—spend more to prevent disease and complications, and save money later&mdash;has bypassed many of these patients for one reason: they lack access to care. Fourteen states have not expanded Medicaid, including several Deep South states where diabetes and obesity rates are highest.

The result of these state-level policy decisions is becoming clear. Research presented at the recent meeting of the American Diabetes Association found a 17% decrease in the risk of amputation when patients lived in states that expanded Medicaid. What’s more, the number of hospital admissions for diabetic foot ulcers plummeted in states that expanded Medicaid, while rising 21% in states that rejected expansion.

None of this is news to Foluso Fakorede, MD, who treats patients at risk of limb loss in the Mississippi Delta. Fakorede spoke with 

 about his work in Mississippi, through his practice, Cardiovascular Solutions of Central Mississippi. 

Heart Failure Coverage Success Seen in Medicaid Expansion States

Diabetes Shouldn't Cost Patients Their Legs

Understanding Diabetes Risks Can Save Your Limbs

Amid progress in diabetes treatments and technology, the rate of amputations rose 50% between 2009 and 2015. African American patients lose limbs at triple the rate of other groups. 
The mission of the Affordable Care Act&mdash;spend more to prevent disease and complications, and save money later&mdash;has bypassed many of these patients for one reason: they lack access to care.

Why Amputations Are on the Rise in Some States, Even as Diabetes Care Improves

 recaps the top managed care news of the week.

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.